Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Humacyte (HUMA) Debt to Equity (2024 - 2025)

Humacyte has reported Debt to Equity over the past 2 years, most recently at -$4.37 for Q3 2025.

  • Quarterly results put Debt to Equity at -$4.37 for Q3 2025, down 347.94% from a year ago — trailing twelve months through Sep 2025 was -$4.37 (down 347.94% YoY), and the annual figure for FY2024 was -$1.24, changed.
  • Debt to Equity for Q3 2025 was -$4.37 at Humacyte, down from $16.92 in the prior quarter.
  • Over the last five years, Debt to Equity for HUMA hit a ceiling of $16.92 in Q2 2025 and a floor of -$4.37 in Q3 2025.